IPHARMA is a contract research organization specialized in conducting clinical trials of investigational drugs in the Russian Federation and the EAEU.


IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center.


Download our company brochure

Quick facts 2012-2020
#1 CRO in Russia according to the results of 2018.
Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2018.








Products in clinical pipeline

Protocols written


Regulatory approvals


Clinical sites


Healthy volunteers enrolled


Patients enrolled


Original drugs and medical devices filed for registration

Cases and webinars

​IPHARMA continue to hold a series of webinars on Youtube channel.

We share our knowledge and experience in clinical research with a wide audience by means of free webinars in witch we discuss the current issues of drug development and safety.

Advantages of working with IPHARMA

1. Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2018.

2. Opportunities for drug localization, investments, and market access.

3. Full cycle of drug development: formulation, batches, QC, preclinical, clinical.

4. Medical and PV expertise with access to top scientists and KOLs.

5. Quality management systems and experienced staff.

IPHARMA contacts


5, Nobel street, Skolkovo Innovative Centre,  Moscow, 121205, Russia

Tel.: +7 (495) 276-11-43 
Fax: +7 (495) 276-11-47

E-mail: info@ipharma.ru

Personal data processing and storage policy


© 2021 IPHARMA

  • Facebook Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon